158 related articles for article (PubMed ID: 11753645)
41. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
[TBL] [Abstract][Full Text] [Related]
42. The CXXC Zn binding motifs of the human papillomavirus type 16 E7 oncoprotein are not required for its in vitro transforming activity in rodent cells.
Braspenning J; Marchini A; Albarani V; Levy L; Ciccolini F; Cremonesi C; Ralston R; Gissmann L; Tommasino M
Oncogene; 1998 Feb; 16(8):1085-9. PubMed ID: 9519882
[TBL] [Abstract][Full Text] [Related]
43. E6/E7 proteins of HPV type 16 and ErbB-2 cooperate to induce neoplastic transformation of primary normal oral epithelial cells.
Al Moustafa AE; Foulkes WD; Benlimame N; Wong A; Yen L; Bergeron J; Batist G; Alpert L; Alaoui-Jamali MA
Oncogene; 2004 Jan; 23(2):350-8. PubMed ID: 14724563
[TBL] [Abstract][Full Text] [Related]
44. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein.
Münger K; Basile JR; Duensing S; Eichten A; Gonzalez SL; Grace M; Zacny VL
Oncogene; 2001 Nov; 20(54):7888-98. PubMed ID: 11753671
[TBL] [Abstract][Full Text] [Related]
45. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
[TBL] [Abstract][Full Text] [Related]
46. [Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].
Velazquez Torres A; Gariglio Vidal P
Rev Invest Clin; 2002; 54(3):231-42. PubMed ID: 12183893
[TBL] [Abstract][Full Text] [Related]
47. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer.
Hamada K; Shirakawa T; Gotoh A; Roth JA; Follen M
Gynecol Oncol; 2006 Dec; 103(3):820-30. PubMed ID: 16908054
[TBL] [Abstract][Full Text] [Related]
48. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer.
Fujii T; Saito M; Iwasaki E; Ochiya T; Takei Y; Hayashi S; Ono A; Hirao N; Nakamura M; Kubushiro K; Tsukazaki K; Aoki D
Int J Oncol; 2006 Sep; 29(3):541-8. PubMed ID: 16865269
[TBL] [Abstract][Full Text] [Related]
49. Improved immunodetection of human papillomavirus E7.
Jeon JH; Cho SY; Kim CW; Shin DM; Kwon JC; Choi KH; Kim IG
Exp Mol Med; 2002 Dec; 34(6):496-9. PubMed ID: 12526093
[TBL] [Abstract][Full Text] [Related]
50. Molecular pathways executing the "trophic sentinel" response in HPV-16 E7-expressing normal human diploid fibroblasts upon growth factor deprivation.
Eichten A; Rud DS; Grace M; Piboonniyom SO; Zacny V; Münger K
Virology; 2004 Feb; 319(1):81-93. PubMed ID: 14967490
[TBL] [Abstract][Full Text] [Related]
51. NFI-Ski interactions mediate transforming growth factor beta modulation of human papillomavirus type 16 early gene expression.
Baldwin A; Pirisi L; Creek KE
J Virol; 2004 Apr; 78(8):3953-64. PubMed ID: 15047811
[TBL] [Abstract][Full Text] [Related]
52. The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300.
Zimmermann H; Degenkolbe R; Bernard HU; O'Connor MJ
J Virol; 1999 Aug; 73(8):6209-19. PubMed ID: 10400710
[TBL] [Abstract][Full Text] [Related]
53. Comparison of the binding of the human papillomavirus type 16 and cottontail rabbit papillomavirus E7 proteins to the retinoblastoma gene product.
Haskell KM; Vuocolo GA; Defeo-Jones D; Jones RE; Ivey-Hoyle M
J Gen Virol; 1993 Jan; 74 ( Pt 1)():115-9. PubMed ID: 8380832
[TBL] [Abstract][Full Text] [Related]
54. The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors.
Antinore MJ; Birrer MJ; Patel D; Nader L; McCance DJ
EMBO J; 1996 Apr; 15(8):1950-60. PubMed ID: 8617242
[TBL] [Abstract][Full Text] [Related]
55. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7.
Lee JO; Russo AA; Pavletich NP
Nature; 1998 Feb; 391(6670):859-65. PubMed ID: 9495340
[TBL] [Abstract][Full Text] [Related]
56. The human papilloma virus E7 oncoprotein inhibits transforming growth factor-beta signaling by blocking binding of the Smad complex to its target sequence.
Lee DK; Kim BC; Kim IY; Cho EA; Satterwhite DJ; Kim SJ
J Biol Chem; 2002 Oct; 277(41):38557-64. PubMed ID: 12145312
[TBL] [Abstract][Full Text] [Related]
57. Analysis of the interaction between human papillomavirus type 16 E7 and the TATA-binding protein, TBP.
Phillips AC; Vousden KH
J Gen Virol; 1997 Apr; 78 ( Pt 4)():905-9. PubMed ID: 9129664
[TBL] [Abstract][Full Text] [Related]
58. Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600.
Huh KW; DeMasi J; Ogawa H; Nakatani Y; Howley PM; Münger K
Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11492-7. PubMed ID: 16061792
[TBL] [Abstract][Full Text] [Related]
59. Dimerization of the human papillomavirus E7 oncoprotein in vivo.
Clemens KE; Brent R; Gyuris J; Münger K
Virology; 1995 Dec; 214(1):289-93. PubMed ID: 8525630
[TBL] [Abstract][Full Text] [Related]
60. Skip interacts with the retinoblastoma tumor suppressor and inhibits its transcriptional repression activity.
Prathapam T; Kühne C; Banks L
Nucleic Acids Res; 2002 Dec; 30(23):5261-8. PubMed ID: 12466551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
